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Abstract
Human cationic and anionic trypsins are sulfated on Tyr154, a residue which helps to shape the prime side substrate-
binding subsites. Here, we used phage display technology to assess the significance of tyrosine sulfation for the specificity
of human trypsins. The prime side residues P19–P49 in the binding loop of bovine pancreatic trypsin inhibitor (BPTI) were
fully randomized and tight binding inhibitor phages were selected against non-sulfated and sulfated human cationic
trypsin. The selection pattern for the two targets differed mostly at the P29 position, where variants selected against non-
sulfated trypsin contained primarily aliphatic residues (Leu, Ile, Met), while variants selected against sulfated trypsin were
enriched also for Arg. BPTI variants carrying Arg, Lys, Ile, Leu or Ala at the P29 position of the binding loop were purified and
equilibrium dissociation constants were determined against non-sulfated and sulfated cationic and anionic human trypsins.
BPTI variants harboring apolar residues at P29 exhibited 3–12-fold lower affinity to sulfated trypsin relative to the non-
sulfated enzyme, whereas BPTI variants containing basic residues at P29 had comparable affinity to both trypsin forms.
Taken together, the observations demonstrate that the tyrosyl sulfate in human trypsins interacts with the P29 position of
the substrate-like inhibitor and this modification increases P29 selectivity towards basic side chains.
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Introduction
The human pancreas secretes two trypsinogen isoforms in large
quantities, anionic and cationic trypsinogens, which account for
more than 95% of total trypsinogen content in the pancreatic juice
[1]. The two isoforms are highly similar, with about 90% sequence
identity. Human trypsinogens become post-translationally sulfated
on Tyr154 by the enzyme tyrosylprotein sulfotransferase 2
(TPST2) in the Golgi apparatus [2,3]. Sulfation in the pancreas
is quantitative, whereas trypsinogen expressed in tumors and
possibly other tissues may not be sulfated [4]. Trypsinogen
sulfation was first observed by Scheele et al. (1981) who
demonstrated radioactive sulfur incorporation into trypsinogens
in human pancreatic slices incubated with labeled sodium sulfate
[1]. The site of sulfation was first revealed by crystallographic
studies on native human cationic trypsin by Gaboriaud et al.
(1996) who described the presence of a modification on Tyr154,
which was incorrectly identified as phosphorylation [5]. In our
more recent studies, we isolated and identified the sulfated tyrosine
amino acid from hydrolyzed pancreatic trypsinogens, and
demonstrated that incorporation of radioactive sulfur was abol-
ished by mutation of Tyr154 [6]. Other investigators used mass
spectrometry to confirm tyrosine sulfation of trypsinogens [4,7]. In
characterizing the sequence requirements for sulfation of Tyr154,
we found that Asp153 is the main determinant, and that the
common African p.D153H variation in anionic trypsinogen causes
loss of tyrosine sulfation [8].
The functional significance of tyrosine sulfation in human
trypsinogens has remained uncertain so far. Studies on other
tyrosine-sulfated proteins as well as phenotypes of TPST1 and
TPST2 knock-out animals indicate that the primary function of
tyrosine sulfation is modulation of protein–protein interactions
among secreted and/or membrane proteins [2,3,9–12]. Autoac-
tivation of human cationic trypsinogen was somewhat increased by
sulfation but a similar effect was not observed with anionic
trypsinogen [6,8]. Increased trypsinogen autoactivation has been
implicated as a pathogenic mechanism in chronic pancreatitis, but
a genetic study analyzing human TPST2 variants found no
association with chronic pancreatitis [13]. More detailed compar-
ative analysis of non-sulfated and sulfated anionic trypsins did not
reveal any appreciable differences with respect to catalytic activity
on a variety of substrates, activation by enteropeptidase, proteo-
lytic stability or cellular expression [8].
In the present study, we used phage display technology and
inhibitor binding experiments to compare the prime side substrate
specificity of non-sulfated and sulfated trypsins. These studies were
motivated by the observation that Tyr154 is located on the prime
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side of the trypsin substrate binding cleft and appears to form part
of the S29 subsite (Schechter and Berger nomenclature [14]), and
thus sulfation may result in altered interactions between human
trypsins and their inhibitors and substrates.
Experimental Procedures
Amino acid numbering
Bovine pancreatic trypsin inhibitor (BPTI) amino acid residues
are numbered starting from the first amino-acid of the 58-amino-
acid mature, processed protein [15]. Tyr154 in human cationic
trypsinogen is numbered starting from the initiator Met of the
primary translation product (pre-trypsinogen). This residue
corresponds to Tyr151 in the conventional chymotrypsin num-
bering.
Plasmid construction and mutagenesis
The pTrapT7 expression plasmids containing the coding DNA
of human cationic and anionic trypsinogens were described
previously [16–18]. The pPICZ-alpha Pichia pastoris expression
plasmid containing the coding sequence for BPTI was described
earlier [19]. BPTI mutants were created by overlap extension
PCR mutagenesis and cloned into the pPICZ-alpha plasmid.
Expression, refolding and purification of human cationic
and anionic trypsinogens
Non-sulfated trypsinogens were expressed in E. coli BL21(DE3),
re-folded in vitro and purified with ecotin affinity chromatography
as described [16–18,20,21]. Sulfated anionic and cationic trypsin-
ogens were isolated from human pancreatic juice with Mono-Q
ion exchange chromatography followed by ecotin affinity chro-
matography, as described previously [6,22]. Trypsinogen was
activated with 14 ng/mL (final concentration) human enteropep-
tidase (R&D Sytems) in 0.1 M Tris-HCl (pH 8.0) and 1 mM
CaCl2. Trypsin concentrations were determined with active site
titration against ecotin.
Expression and purification of BPTI variants
BPTI was expressed and purified using protocols similar to
those we have described previously [23]. Pichia pastoris X-33
transformants were grown for 3 days at 30uC using 500 mL
buffered methanol-complex medium (BMMY). BPTI was precip-
itated from the medium with ammonium sulfate at 95% saturation
at 22uC. After centrifugation the protein pellet was dissolved in
100 mL 10 mM Tris-HCl (pH 8.0) and dialyzed against 7 L of
10 mM Tris-HCl (pH 8.0). The dialyzed BPTI was purified on a
Q-Sepharose anion exchanger column followed by an affinity
chromatography step using immobilized bovine trypsin. The
concentration of BPTI mutants was determined with active site
titration against human cationic trypsin.
Selection of inhibitor phages against non-sulfated and
sulfated human cationic trypsins
The pComb3H plasmid harboring the coding sequence of BPTI
[24] was a kind gift from Jacek Otlewski, University of Wroclaw. A
library was designed in which the P1 residue (Lys15 in wild-type
BPTI) was mutated to Arg, and the P19–P49 residues (Ala16,
Arg17, Ile18, and Ile19) and the P199 residue (Val34) were
completely diversified by custom synthesis substituting nucleotide
mixtures NNS (N=25% C, 25% A, 25% G, 25% T; S= 50% G,
50% C) for the diversified codons. The non-amplified library was
PCR amplified, cloned into the phage display vector pComb3H+
BPTI using restriction enzymes XhoI and SpeI, and transformed
into the E. coli strain TG1, to yield a cloned library of 2.96107
transformants (GeneArt Life Technologies). This library size
represented approximately 9-fold coverage of the theoretically
possible number of encoded amino acid sequence combinations
(3.26106), but represented slightly less than the theoretically
possible number of nucleic acid sequence combinations (3.46107).
Sequencing of 90 random clones confirmed the unbiased diversity
of the library. Non-sulfated and sulfated human cationic trypsin
was immobilized overnight in a Nunc 96-well Maxisorp plate
using two wells for each protein and 10 mg protein per well in
100 mL of 0.1 M Tris-HCl (pH 8.0) and 1 mM CaCl2 at 4uC. The
wells were blocked with 200 mL 5 mg/mL BSA dissolved in TBS
(50 mM Tris-HCl (pH 7.5), 150 mM NaCl) for 1 h at 22uC. Two
control wells were treated with BSA without trypsin. The wells
were rinsed six times with TBS containing 0.1% Tween 20.
Phages (,26107 particles per well) were added to the wells in TBS
Figure 1. Modeled interaction of sulfated Tyr154 in human
cationic trypsin with bound BPTI. (A) Ribbon diagram of sulfated
cationic trypsin–BPTI complex. The model was created by fitting the
sulfated trypsin (1TRN) on the structure of non-sulfated trypsin in
complex with BPTI inhibitor (2RA3). (B) Prime side interactions of BPTI
with sulfated cationic trypsin. The tyrosyl-sulfate (red) is within 2–4 A˚ of
the P29 Arg17 of BPTI.
doi:10.1371/journal.pone.0102063.g001
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containing 0.1% Tween 20 and incubated for 1 h at 22uC. The
wells were washed 10 times with TBS, 0.1% Tween 20 and bound
phages were eluted with 100 mL 0.2 M glycine-HCl buffer
(pH 2.2) per well for 10 min at 22uC. The eluted phage
populations from two wells were pooled and neutralized with
20 mL of 1.5 M Tris-HCl (pH 8.8). E. coli SS320 (MC 1061 F’)
strain (Lucigen) was inoculated in 5 mL SB medium containing
0.36% glucose. At OD600 ,0.5 the E. coli cells were infected with
200 mL of the eluted phages. Ten mL of the infected cells were
used for phage titration using carbenicillin plates for selection. The
remaining infected E. coli cells served for phage amplification in
the presence of VCSM13 helper phage in 50 mL Super Broth
medium with glucose containing 50 mg/mL carbenicillin and
kanamycin with overnight shaking at 37uC. The cells were
collected by centrifugation; the supernatant containing the
amplified phagemid library was precipitated with PEG8000,
washed twice with TBS and re-suspended in 400 mL TBS. The
amplified phagemid library served as input in the next panning
cycle.
Phage ELISA of the selected library members
Individual clones from the third cycle were tested in phage
ELISA. E. coli colonies containing the pComb3H-BPTI plasmid
were grown overnight in 3 mL LB medium with 100 mg/mL
ampicillin at 37uC in the presence of VCSM13 helper phage (109
phages/mL). Cells were separated from the phage-containing
supernatant by centrifugation. Non-sulfated and sulfated trypsins
(2 mg/well) were immobilized overnight to a Maxisorp plate at
4uC. Wells were blocked with 5 mg/mL BSA dissolved in TBS for
1 h at 22uC. Control wells were also blocked without trypsin
treatment. Wells were washed four times with TBS containing
0.1% Tween 20. Aliquots (50 mL) of phage supernatant of
individual clones were transferred to the wells and incubated for
1 h at 22uC. Wells were rinsed six times with TBS containing
0.1% Tween 20. Horseradish peroxidase (HRP)-conjugated anti-
M13 antibody (1 mg/mL stock, GE Healthcare) was diluted 5000-
fold with TBS containing 5 mg/mL BSA and 0.1% Tween 20 and
50 mL was added to each well and incubated for 30 min at 22uC.
The wells were rinsed six times with TBS containing 0.1% Tween
20 and twice with TBS. ELISA signal was measured spectropho-
Figure 2. BPTI variants used for phage display and binding experiments. (A) Ribbon model and primary structure of K15R mutant BPTI
indicating in black the randomized amino acid positions in the phage library. (B) Binding loop sequences of five BPTI variants designed to test the
significance of the P29 position. See text for details.
doi:10.1371/journal.pone.0102063.g002
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tometrically at 450 nm in a microplate reader after adding 50 mL
of 1-Step Turbo TMB-ELISA HRP substrate (Thermo Scientific),
incubating for 10 min and stopping the reaction with 50 mL 2 M
sulfuric acid. Phage clones yielding ELISA signals against
immobilized trypsin at least 3-fold above the BSA control were
selected for sequencing.
Sequence analysis
DNA minipreps of the pComb3H-BPTI plasmids of individual
clones were analyzed by sequencing using the reverse primer 59-
AGC GTT TGC CAT CTT TTC ATA ATC-39. Clones with
unique DNA sequences were aligned and amino acid frequencies
at the randomized positions were determined. Where indicated,
these frequencies were normalized to the expected codon
frequencies in the NNS degenerated set, to eliminate the effects
of codon bias. For logo representation of the normalized results an
input sequence dataset containing 100 sequences was generated
representing the normalized amino acid frequencies at each
randomized position [25,26]. The sequence logos were created by
the WebLogo program [27].
Equilibrium binding assays
Binding of BPTI variants to non-sulfated and sulfated cationic
and anionic trypsins were characterized by determining the
dissociation constant values in equilibrium (KD) as described
before [26]. BPTI variants (0–100 pM) and trypsin (50 pM) were
incubated in 0.1 M Tris-HCl (pH 8.0), 1 mM CaCl2, and 0.05%
Tween 20 (final concentrations) for 15 h at 22uC in black 96-well
plates in 200 mL volume. Free trypsin concentrations were
determined with spectrofluorometry after addition of 5 mL
6 mM Z-Gly-Pro-Arg-AMC and measuring the rate of substrate
cleavage using excitation and emission wavelengths of 380 nm and
460 nm, respectively. KD values were determined by plotting the
free protease concentration as a function of the total inhibitor
concentration. The experimental data were fitted with the
following equation: y =E–(E+x+K–sqrt((E+x+K)2–4Ex))/2, where
Figure 3. Sequence logo representation of phage display-selected BPTI variants against non-sulfated and sulfated trypsin.
Randomized positions P19, P29, P39, P49 and P199 are shown; the P1 position which was fixed as Arg is also included for reference. The overall height
of the stack of symbols indicates the degree of sequence conservation at that position, whereas the height of symbols within the stack indicates the
relative frequency of each amino acid. The colors indicate the chemical properties of the amino acid side chains; apolar is black, aromatic is orange,
polar is green, acidic is red and basic is blue. The logos were created with the WebLogo program [27]. (A) Sequencing data from 28 and 27
independent BPTI clones selected after three panning cycles against non-sulfated and sulfated trypsins, respectively (Table 1). (B) Sequencing data
was normalized to expected codon frequencies as described in Experimental Procedures.
doi:10.1371/journal.pone.0102063.g003
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the independent variable x represents the total inhibitor concen-
tration, the dependent variable y is the free protease concentration
in equilibrium, K is KD, and E designates the total protease
concentration.
Results
Phage display studies
To assess the potential impact of sulfation on substrate
recognition by trypsin from a structural perspective, we fitted
the crystal structure of native, sulfated cationic trypsin (Protein
Data Bank code 1TRN) onto the structure of non-sulfated,
recombinant cationic trypsin in complex with the trypsin inhibitor
BPTI (Protein Data Bank code 2RA3) [5,28]. As shown in
Figure 1, this model indicates that the sulfated Tyr154 lies within
2–4 A˚ distance of the P29 Arg17 side chain of BPTI. The position
of Tyr154 suggests that sulfation might modify the selectivity of
trypsin toward prime side residues of inhibitors and substrates; the
P29 position in particular.
To test this hypothesis, we designed a phage display library
using BPTI as scaffold where the prime side amino acid residues in
the reactive site loop, from P19 through P49, were fully
randomized (Figure 2A). In addition, the P1 Lys residue was
changed to Arg, and Val34 in the BPTI scaffold (P199), which
interacts with the P29 position, was also randomized. Phages
carrying tight binding BPTI inhibitors were selected against non-
sulfated and sulfated human cationic trypsins. Following three
selection cycles and verification by phage ELISA, selected clones
were subjected to DNA sequencing. The overall selection pattern
was highly similar for non-sulfated and sulfated trypsins, charac-
terized by a slight-to-moderate preference for small side-chains at
P19 (Ala, Gly, Ser), mostly aliphatic amino-acids at P29 (Ile, Met,
Leu); acidic residues at P39 (Asp, Glu) (Table 1 and Figure 3) and
no selection at P49. At position P199 mostly the native Val was
selected against non-sulfated trypsin, whereas a small enrichment
for residues with short side chains (Ala, Gly, Ser) was detected in
the selected clones against sulfated trypsin (Table 1).
The most significant difference in the selection pattern between
non-sulfated and sulfated trypsins was at the P29 position, where
Arg was selected against sulfated trypsin with the highest
frequency (seven occurrences), whereas only one clone selected
against non-sulfated trypsin carried a P29 Arg (Table 1). However,
when the selected sequences were normalized to reflect the
expected codon frequencies in the phage library, the P29 Arg
preference became less significant (Figure 3B). To exclude the
possibility that a display bias in the BPTI library might account for
the observed selection pattern, a panning cycle was performed
against immobilized anti-BPTI IgG. One hundred independent
ELISA-positive clones were sequenced and all investigated
positions in the library were found fully random. Taken together,
the phage display selection results indicate that sulfation of cationic
trypsin increases selectivity towards P29 Arg versus hydrophobic
P29 side chains.
BPTI binding studies
To test the significance of the P29 position in a more direct
fashion, we designed individual BPTI variants carrying Arg, Lys,
Leu, Ile or Ala at P29 (Figure 2). On the basis of the phage display
selection pattern, positions P19, P39, P49 and P199 were fixed as
Ala, Asp, Ile, and Val, respectively. The five BPTI variants were
expressed in Pichia pastoris and purified to homogeneity. To
characterize BPTI binding to non-sulfated and sulfated cationic
trypsins, we performed equilibrium binding assays and determined
the equilibrium dissociation constants (KD) (Figure 4A). All
inhibitor variants exhibited high affinity (KD ranged form
0.5 pM to 13 pM). Variants with Arg or Lys at P29 bound to
non-sulfated and sulfated cationic trypsins with unchanged
affinities; however, variants harboring apolar residues (Ile, Leu
or Ala) at P29 exhibited 6–12-fold weaker affinity to sulfated
trypsin relative to the non-sulfated enzyme (Table 2, Figure 4B).
To confirm and extend these observations, the BPTI variants were
also tested against non-sulfated and sulfated human anionic
trypsins. Again, equilibrium dissociation constant values indicated
high affinity binding (KD range 0.3–4 pM) (Table 2). Similarly to
our findings with cationic trypsin, no difference in binding to non-
sulfated and sulfated anionic trypsins was found with variants
carrying Arg or Lys at P29, whereas inhibitors containing a
hydrophobic P29 residue bound to sulfated anionic trypsin with
approximately 3–7-fold weaker affinity compared to non-sulfated
anionic trypsin (Table 2, Figure 4C).
When the averaged KD values for BPTI variants with apolar
and basic P29 residues are considered, a small, 2–3-fold selectivity
for apolar versus basic P29 residues is evident in non-sulfated
trypsin (0.8 pM versus 2.4 pM in cationic trypsin and 0.6 pM
Table 2. Inhibition of non-sulfated and sulfated cationic and anionic trypsins by phage display-selected BPTI variants.
BPTI P29 Non-sulfated Sulfated
R 0.960.1 1.060.1
K 3.960.4 3.360.1
Cationic trypsin L 1.260.1 13.463.6
I 0.560.1 3.260.1
A 0.760.1 7.960.5
R 0.760.3 0.460.3
K 1.660.1 1.360.2
Anionic trypsin L 1.260.1 4.060.3
I 0.360.2 1.360.1
A 0.360.2 2.260.1
Equilibrium dissociation constants (KD) were determined as described in Experimental Procedures and values were expressed in picomolar units of concentration.
Averages6 SEM from two independent KD determinations are indicated. Note that each KD value was determined from five independent binding events (see Figure 4A)
and each binding event was assayed in duplicate.
doi:10.1371/journal.pone.0102063.t002
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versus 1.2 pM in anionic trypsin). This trend becomes reversed in
sulfated trypsin, which exhibits a 3–4-fold preference for basic P29
residues over hydrophobic side chains (8.2 pM versus 2.2 pM in
cationic trypsin and 2.5 pM versus 0.9 pM in anionic trypsin).
When the same calculations are performed for Arg versus all
apolar P29 side chains, no selectivity is observed with non-sulfated
trypsin, whereas sulfated trypsin prefers Arg over hydrophobic P29
amino acids by a factor of 6–8. Thus, the net effect of tyrosine
sulfation on human trypsins is an increase in P29 selectivity
towards basic residues versus hydrophobic residues by about an
order of magnitude.
Discussion
In the present study we used phage display technology to
investigate the significance of tyrosine sulfation in the substrate
binding specificity of human cationic and anionic trypsins. Our
findings demonstrate that the negatively charged sulfate group on
Tyr154 modifies the P29 selectivity of trypsins; it slightly inhibits
binding of hydrophobic side chains (Ala, Ile, Leu), whereas it
maintains an essentially unaltered affinity for positively charged
Arg and Lys residues. The overall effect of sulfation is a 6–12-fold
increase in selectivity towards basic P29 residues. This conclusion is
consistent with structural modeling showing steric proximity
between Tyr154 and the P29 side chain of bound inhibitor (see
Figure 1).
We also found that human cationic trypsin favored residues
with short side chains (Ala, Gly, or Ser) at P19 and acidic residues
(Asp or Glu) at P39; these selection patterns were independent of
sulfation. These observations differ from previous studies mapping
the S19 subsite of bovine and rat trypsins using acyl-transfer
experiments, which found that the S19 site exhibited broad
specificity with an apparent preference toward hydrophobic side
chains rather than Ala/Gly/Ser as observed here [29–33].
Similarly broad specificity without selectivity for Asp/Glu was
observed for the S39 site in rat trypsin [30]. The different selection
pattern in our experiments may be related to several differences
between the acyl-transfer experiments and the phage display
approach taken here. An important difference is that preferences
revealed in acyl-transfer experiments encompass both binding
affinity and catalytic competence for ligation; a successful
nucleophile must not only bind to the prime side subsites of the
enzyme, but also carry out productive nucleophilic attack on a
second substrate occupying the nonprime side subsites of the
enzyme. By contrast, phage display selection unmasks the binding
preferences of the enzyme uncoupled from catalytic rates. Another
contributing factor may be the conformational constraints of the
relatively rigid BPTI scaffold. Indeed, mutational analysis of the
P19 position of BPTI found Ala, Gly and Ser as the preferred
residues for tight binding to trypsin, chymotrypsin and plasmin
[34]. Of interest, another study mapping binding preferences of
bovine trypsin using fluorescence-quenched substrates found a
pattern of specificity more closely approximating our results, in
which Ser and Ala (in addition to Arg) were preferred residues at
P19, and Asp was among the more favored residues at P39 [35].
The P19 and P39 specificities observed may be interrelated, as
these subsites often have a cooperative relationship. Owing to the
extended (canonical) backbone conformation of bound inhibitors
and substrates, side chains at the P19 and P39 positions point in the
same direction and their interactions with the S19 and S39 subsites
are contiguous. Crystal structures indicate that Lys66 (correspond-
ing to Lys60 in conventional chymotrypsin numbering) may be a
determinant of S19 and S39 specificity [36], and the Asp/Glu
selection at P39 may be explained by a favorable electrostatic
interaction. This interaction, in turn, may partially obstruct the
S19 subsite, resulting in the selection of small volume side chains at
P19 instead of larger hydrophobic residues. A similarly restricted
P19 preference is also characteristic of thrombin, where Lys60f
(chymotrypsin numbering) occludes the S19 subsite and limits its
specificity to amino-acids with small side-chains [37,38].
The biological significance of the observed P29 selectivity for
basic amino acids in sulfated human trypsins remains unclear. As
detailed in the introduction, previous studies were unable to
Figure 4. Inhibition of non-sulfated and sulfated trypsin by
phage-display selected BPTI variants. (A) Representative inhibitor
binding experiments are shown using sulfated cationic trypsin and BPTI
variants with a P29 Arg and Leu. See Experimental Procedures for details.
(B) The effect of the P29 amino acid in BPTI on the inhibition of non-
sulfated (black bars) and sulfated (gray bars) human cationic trypsin. KD
values from Table 2 were plotted. (C) The effect of the P29 amino acid in
BPTI on the inhibition of non-sulfated (black bars) and sulfated (gray
bars) human anionic trypsin. KD values from Table 2 were graphed.
doi:10.1371/journal.pone.0102063.g004
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identify a convincing role for tyrosine sulfation in trypsin function.
The large majority of vertebrate trypsins do not appear to be
sulfated, as judged by the absence of Tyr154 or the required
sulfation motif (see Table 1 in reference [6]). This suggests that
trypsin sulfation in humans may have evolved to facilitate the
digestion of specialized substrates present in the primate diet only.
Alternatively, the true evolutionary driving force of trypsin
sulfation may have been unrelated to catalytic activity and the
relatively small changes in substrate specificity may be inconse-
quential in the digestive function of trypsins. Yet a third possibility
is that sulfation may enhance the catalytic capability of trypsins
toward protein substrates by weakening prime side interactions.
For protein substrates, strong affinity between the prime side
residues and corresponding protease subsites will have the effect of
retarding the deacylation step of the reaction. For good substrates
of trypsin, deacylation can be the rate determining step in the
overall reaction [39,40]. As a consequence, by diminishing prime
side affinity for the majority of protein substrates the effect of
Tyr154 sulfation may be to accelerate enzyme turnover. Interest-
ingly, rat anionic trypsin-2 contains a Glu residue in place of
Tyr154 and this negatively charged side chain may mimic the
function of a sulfated Tyr154. Indeed, a salt bridge formed
between Glu154 and the P29 Arg of the bound inhibitor is evident
in the crystal structure of rat anionic trypsin-2 with BPTI [36].
Furthermore, prime side mapping of rat trypsin using acyl-transfer
experiments demonstrated an S29 preference for positively
charged residues [30].
In summary, we demonstrated that sulfation of human anionic
and cationic trypsins on Tyr154 increases selectivity towards basic
versus apolar residues at the P29 position of inhibitors that bind in
a substrate-like fashion. Although the increase in selectivity is
relatively small, we speculate that this post-translational change in
substrate specificity may facilitate digestion of a broader range of
dietary proteins.
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